Linfox invests AU$53m in Australian pharmaceutical industry


Linfox has announced that it has invested more than AU$50m in a pharmaceutical supply chain hub in New South Wales, Australia.

The purpose-built facility, which can hold up to 30,000 pallets, has ambient, chilled and frozen storage areas and the capacity to cater to a range of ambient and temperature sensitive products. The hub will act as a national distribution centre and includes secondary packaging facilities.

The investment forms part of the company’s broader strategy to enhance the Australian pharmaceutical industry by increasing efficiency and transparency in the supply chain. Aspen, MundiPharma, Perrigo and ResMed have all shown support for the facility and will use the 29,000 sq m, temperature controlled facility.

Greg Thomas, President FMCG, Linfox said, “This facility is an important hub for Australia’s pharmaceutical supply chain network but our approach means we can also help customers expand into new markets faster and protect product integrity, ensuring regulatory compliance, reducing inventory management costs and streamlining order and billing processes.”

Source: Linfox

GSCi

The world's largest collection of global supply chain intelligence

  • quickly and easily search and gain invaluable insight into the logistics industry
  • Empower everyone from business development executives to CEO level
  • Enhance the role of the market research department